{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:18:07Z","timestamp":1787890687807,"version":"build-2784847793"},"reference-count":74,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T00:00:00Z","timestamp":1787443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005888","name":"Medical University of Lodz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]},{"id":[{"id":"https:\/\/ror.org\/02t4ekc95","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Bisphosphonates (BPs) and Denosumab (DMB) are antiresorptive agents (AA) commonly used in treatment of osteoporosis, multiple myeloma (8.0%), breast cancer (3.3%), prostate cancer (2.9%) and other malignancies (0.7%), bone metastases, and cancer-induced hypercalcemia. However, this therapy is associated with a significant risk of medication-related osteonecrosis of the jaw (MRONJ), particularly after tooth extraction. The aim of this narrative review was to summarize current evidence on measures aimed to reduce the risk of MRONJ after tooth extraction, and to critically discuss the strength of evidence supporting each of these measures. Articles published in the years 2013\u20132025 were reviewed using PubMed, Scopus, Web of Science databases. Available studies were categorized and compared with the use of selected prevention methods. The duration of the treatment, route of administration, dosage and type of AA have a significant impact on the risk of developing MRONJ. Antibiotic prophylaxis is considered in most published preventive protocols. However, the evidence supporting a single optimal regimen is limited. Patients from a high-risk group of MRONJ, demonstrating cancer, who were administered intravenous antiresorptive agents for longer than three years or zoledronic acid, or those with a history of jawbone necrosis or inflammation require prolonged antibiotic therapy (started before the procedure and continued up to 14 days after the procedure). Moreover, studies on the use of platelet-rich fibrin (PRF) and Concentrated Growth Factors (CGF) as a preventive measure have shown promising results in observational studies, along with antibiotic prophylaxis and optimal oral hygiene. Pentoxifylline with tocopherol and low-level laser therapy (LLLT) are recognized as potentially useful non-invasive preventions. However, evidence is limited due to the small sample sizes and heterogenous protocols. Vitamin D levels should be monitored, and oral supplementation should be considered if needed. AA therapy suspension prior to the surgical procedure must always be consulted with the attending physician. A multidisciplinary approach along with well-planned pre- and postoperative care is essential for safe tooth extraction in patients receiving AA therapy.<\/jats:p>","DOI":"10.3390\/ijms27177539","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:47:19Z","timestamp":1787572039000},"page":"7539","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["How to Prepare Patients Receiving Antiresorptive Therapy for Tooth Extraction: A Narrative Review"],"prefix":"10.3390","volume":"27","author":[{"given":"Bartosz","family":"Bielecki-Kowalski","sequence":"first","affiliation":[{"name":"Department of Maxillofacial Surgery, Medical University of Lodz, 251 Pomorska St., 92-213 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4004-6832","authenticated-orcid":false,"given":"Lukasz","family":"Sokalski","sequence":"additional","affiliation":[{"name":"Student Scientific Association, Department of Oral Mucosal and Periodontal Diseases, Medical University of Lodz, 251 Pomorska St., 92-213 Lodz, Poland"},{"name":"Student Scientific Association, Department of Maxillofacial Surgery, Medical University of Lodz, 251 Pomorska St., 92-213 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Majorczyk","sequence":"additional","affiliation":[{"name":"Student Scientific Association, Department of Oral Mucosal and Periodontal Diseases, Medical University of Lodz, 251 Pomorska St., 92-213 Lodz, Poland"},{"name":"Student Scientific Association, Department of Maxillofacial Surgery, Medical University of Lodz, 251 Pomorska St., 92-213 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6619-1434","authenticated-orcid":false,"given":"Natalia","family":"Bielecka-Kowalska","sequence":"additional","affiliation":[{"name":"Department of Oral Mucosal and Periodontal Diseases, Medical University of Lodz, 251 Pomorska St., 92-213 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9694-0950","authenticated-orcid":false,"given":"Sebastian","family":"Klosek","sequence":"additional","affiliation":[{"name":"Department of Oral Mucosal and Periodontal Diseases, Medical University of Lodz, 251 Pomorska St., 92-213 Lodz, Poland"},{"name":"Department of Oral Pathology, Medical University of Lodz, 251 Pomorska St., 92-213 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bone.2011.02.003","article-title":"Bisphosphonates in oncology","volume":"49","author":"Coleman","year":"2011","journal-title":"Bone"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00204-023-03653-7","article-title":"Medication-related osteonecrosis of the jaw (MRONJ): A review of pathogenesis hypothesis and therapy strategies","volume":"98","author":"Jiang","year":"2024","journal-title":"Arch. Toxicol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00784-017-2325-6","article-title":"Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: A systematic review and meta-analysis of the drug suspension protocol","volume":"22","author":"Ramaglia","year":"2018","journal-title":"Clin. Oral Investig."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Lee, E.S., Tsai, M.-C., Lee, J.-X., Wong, C., Cheng, Y.-N., Liu, A.-C., Liang, Y.-F., Fang, C.-Y., Wu, C.-Y., and Lee, I.-T. (2023). Bisphosphonates and Their Connection to Dental Procedures: Exploring Bisphosphonate-Related Osteonecrosis of the Jaws. Cancers, 15.","DOI":"10.3390\/cancers15225366"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"117200","DOI":"10.1016\/j.bone.2024.117200","article-title":"Role of sclerostin deletion in bisphosphonate-induced osteonecrosis of the jaw","volume":"187","author":"Nakashima","year":"2024","journal-title":"Bone"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 Position Paper on Medication-Related Osteonecrosis of the Jaws\u20142022 Update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/phar.2838","article-title":"Evaluation of the efficacy and tolerability of alendronate versus denosumab in kidney transplant patients with reduced bone mineral density","volume":"43","author":"Sayed","year":"2023","journal-title":"Pharmacotherapy"},{"key":"ref_8","first-page":"2305","article-title":"Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: Systematic review and meta-analysis","volume":"29","author":"Srivastava","year":"2021","journal-title":"Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40902-023-00377-7","article-title":"Associated systemic diseases and etiologies of medication-related osteonecrosis of the jaw: A retrospective study of 265 surgical cases","volume":"45","author":"Chang","year":"2023","journal-title":"Maxillofac. Plast. Reconstr. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"ziaf003","DOI":"10.1093\/jbmrpl\/ziaf003","article-title":"Real-world study of medication-related osteonecrosis of the jaw from 2010 to 2023 based on Food and Drug Administration Adverse Event Reporting System","volume":"9","author":"Zhong","year":"2025","journal-title":"JBMR Plus"},{"key":"ref_11","first-page":"2509","article-title":"Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307)","volume":"29","author":"Kizub","year":"2021","journal-title":"Support. Care Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"101931","DOI":"10.1016\/j.jormas.2024.101931","article-title":"Epidemiology, etiopathogenesis, and management of MRONJ: A European multicenter study","volume":"125","author":"Boffano","year":"2024","journal-title":"J. Stomatol. Oral Maxillofac. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00198-023-06732-8","article-title":"Incidence and trend of antiresorptive agent-related osteonecrosis of the jaw from 2016 to 2020 in Kure, Japan","volume":"34","author":"Kunihara","year":"2023","journal-title":"Osteoporos. Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.oooo.2018.09.008","article-title":"Medication-related osteonecrosis of the jaw: Definition and best practice for prevention, diagnosis, and treatment","volume":"127","author":"Mendes","year":"2019","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.adaj.2019.03.006","article-title":"Serum C-terminal cross-linking telopeptide level as a predictive biomarker of osteonecrosis after dentoalveolar surgery in patients receiving bisphosphonate therapy: Systematic review and meta-analysis","volume":"150","author":"Awad","year":"2019","journal-title":"J. Am. Dent. Assoc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1007\/s00784-022-04383-3","article-title":"Is serum C-terminal telopeptide cross-link of type 1 collagen a reliable parameter for predicting the risk of medication-related osteonecrosis of the jaws? A systematic review and meta-analysis of diagnostic test accuracy","volume":"26","author":"Alves","year":"2022","journal-title":"Clin. Oral Investig."},{"key":"ref_17","first-page":"7687","article-title":"Oral health condition in cancer patients under bisphosphonate therapy","volume":"29","year":"2021","journal-title":"Support. Care Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.joms.2021.05.031","article-title":"What is the Risk of Developing Medication-Related Osteonecrosis in Patients With Extraction Sockets Left to Heal by Secondary Intention? A Retrospective Case Series Study","volume":"79","author":"Pippi","year":"2021","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10006-023-01204-z","article-title":"The role of leukocyte and platelet-rich fibrin in the prevention of medication-related osteonecrosis of the jaw, in patients requiring dental extractions: An observational study","volume":"28","author":"Besi","year":"2024","journal-title":"Oral Maxillofac. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e680","DOI":"10.4317\/medoral.18812","article-title":"Case series of 589 tooth extractions in patients under bisphosphonates therapy. Proposal of a clinical protocol supported by Nd:YAG low-level laser therapy","volume":"18","author":"Vescovi","year":"2013","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/SCS.0000000000001665","article-title":"Tooth Extractions in High-Risk Patients Under Bisphosphonate Therapy and Previously Affected With Osteonecrosis of the Jaws: Surgical Protocol Supported by Low-Level Laser Therapy","volume":"26","author":"Vescovi","year":"2015","journal-title":"J. Craniofac. Surg."},{"key":"ref_22","first-page":"e771","article-title":"Prevention of medication related osteonecrosis of the jaw after dentoalveolar surgery: An institution\u2019s experience","volume":"12","author":"Tatar","year":"2020","journal-title":"J. Clin. Exp. Dent."},{"key":"ref_23","unstructured":"Kaczmarzyk, T., Babiuch, K., Hryniewicz, W., Szuta, M., Szel\u0105g, A., Bo\u0142tacz-Rzepkowska, E., Lipski, M., Olczak-Kowalczyk, D., Dominiak, M., and Konopka, T. (2019). Rekomendacje Grupy Roboczej Polskiego Towarzystwa Stomatologicznego i Narodowego Programu Ochrony Antybiotyk\u00f3w w Zakresie Stosowania Antybiotyk\u00f3w w Stomatologii, Narodowy Instytut Lek\u00f3w."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Barone, S., Antonelli, A., Madonna, A., Giudice, A., Borelli, M., and Bennardo, F. (2025). Antibiotic Prophylaxis and Postoperative Therapy in Tooth Extractions for Patients at Risk of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Scoping Review. Antibiotics, 14.","DOI":"10.3390\/antibiotics14121279"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Ristow, O., R\u00fcckschlo\u00df, T., Schnug, G., Moratin, J., Bleymehl, M., Zittel, S., Pilz, M., Sekundo, C., Mertens, C., and Engel, M. (2023). Comparison of Different Antibiotic Regimes for Preventive Tooth Extractions in Patients with Antiresorptive Intake-A Retrospective Cohort Study. Antibiotics, 12.","DOI":"10.3390\/antibiotics12060997"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2334\/josnusd.21-0016","article-title":"Lack of evidence in reducing risk of MRONJ after teeth extractions with systemic antibiotics","volume":"63","author":"Cabras","year":"2021","journal-title":"J. Oral Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jcms.2020.01.014","article-title":"Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review","volume":"48","author":"Fortunato","year":"2020","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/2320206819895836","article-title":"Role of Platelet-Rich Fibrin (PRF) and Platelet-Rich Plasma (PRP) in Oro-Facial Tissue Regeneration: A Narrative Review","volume":"11","author":"Deeb","year":"2020","journal-title":"J. Adv. Oral Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10006-022-01094-7","article-title":"Efficacy of fibrin-rich platelets and leukocytes (L-PRF) in tissue repair in surgical oral procedures in patients using zoledronic acid\u2014Case\u2013control study","volume":"27","author":"Parise","year":"2022","journal-title":"Oral Maxillofac. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4948139","DOI":"10.1155\/2021\/4948139","article-title":"The Role of Platelet-Rich Fibrin (PRF) in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ)","volume":"2021","author":"Miranda","year":"2021","journal-title":"BioMed Res. Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/cre2.775","article-title":"Prevention and management of drug-induced osteonecrosis of the jaws using platelet-rich fibrin: A clinical feasibility study","volume":"9","author":"Alrmali","year":"2023","journal-title":"Clin. Exp. Dent. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jcms.2016.05.004","article-title":"Medication-related osteonecrosis of the jaw: Is autologous platelet concentrate application effective for prevention and treatment? A systematic review","volume":"44","author":"Tobias","year":"2016","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1002\/hed.25944","article-title":"Adjuvant therapies in the management of medication-related osteonecrosis of the jaws: Systematic review","volume":"41","author":"Michellon","year":"2019","journal-title":"Head Neck"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1097\/SCS.0000000000010664","article-title":"Platelet-Rich Plasma in the Prevention and Treatment of Medication-Related Osteonecrosis of the Jaw: A Systematic Review and Meta-Analysis","volume":"35","author":"Aljohani","year":"2024","journal-title":"J. Craniofac. Surg."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jcms.2024.01.007","article-title":"The effectiveness of autologous platelet concentrates in prevention and treatment of medication-related osteonecrosis of the jaws: A systematic review","volume":"52","author":"Nowak","year":"2024","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Tao, L., Gao, Y., Li, Y., Yang, L., Yao, J., Huang, H., Yu, J., Han, B., Wang, B., and Liu, Z. (2024). The preventive effect of photocrosslinked Hep\/GelMA hydrogel loaded with PRF on MRONJ. BMC Oral Health, 24.","DOI":"10.1186\/s12903-024-04792-8"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Niemczyk, W., \u017burek, J., Niemczyk, S., K\u0119pa, M., Zi\u0119ba, N., Misio\u0142ek, M., and Wiench, R. (2025). Antibiotic-Loaded Platelet-Rich Fibrin (AL-PRF) as a New Carrier for Antimicrobials: A Systematic Review of In Vitro Studies. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26052140"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Bennardo, F., Gallelli, L., Palleria, C., Colosimo, M., Fortunato, L., De Sarro, G., and Giudice, A. (2023). Can platelet-rich fibrin act as a natural carrier for antibiotics delivery? A proof-of-concept study for oral surgical procedures. BMC Oral Health, 23.","DOI":"10.1186\/s12903-023-02814-5"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10103-017-2400-x","article-title":"Laser for bone healing after oral surgery: Systematic review","volume":"33","author":"Noba","year":"2018","journal-title":"Lasers Med. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Amaroli, A., Colombo, E., Zekiy, A., Aicardi, S., Benedicenti, S., and De Angelis, N. (2020). Interaction between Laser Light and Osteoblasts: Photobiomodulation as a Trend in the Management of Socket Bone Preservation\u2014A Review. Biology, 9.","DOI":"10.3390\/biology9110409"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Dompe, C., Moncrieff, L., Matys, J., Grzech-Le\u015bniak, K., Kocherova, I., Bryja, A., Bruska, M., Dominiak, M., Mozdziak, P., and Skiba, T.H.I. (2020). Photobiomodulation\u2014Underlying Mechanism and Clinical Applications. J. Clin. Med., 9.","DOI":"10.3390\/jcm9061724"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40902-016-0095-8","article-title":"Effect of low-level laser therapy on bisphosphonate-treated osteoblasts","volume":"38","author":"Shin","year":"2016","journal-title":"Maxillofac. Plast. Reconstr. Surg."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Todea, D.C., Podoleanu, A.G., and Duma, V.-F. (2016). Effect of Nd:YAG laser light on post-extractive socket healing in rats treated with zoledronic acid and dexamethasone. Proceedings of the Sixth International Conference on Lasers in Medicine, Bucharest, Romania, 7\u20139 May 2015, SPIE.","DOI":"10.1117\/12.2191847"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"297","DOI":"10.5978\/islsm.12-RE-01","article-title":"Low-level laser therapy: A standard of supportive care for cancer therapy-induced oral mucositis in head and neck cancer patients?","volume":"21","author":"Jadaud","year":"2012","journal-title":"Laser Ther."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Scribante, A., Ghizzoni, M., Pellegrini, M., Pulicari, F., and Spadari, F. (2023). Laser Devices and Autologous Platelet Concentrates in Prevention and Treatment of Medication-Related Osteonecrosis of the Jaws: A Systematic Review. Medicina, 59.","DOI":"10.3390\/medicina59050972"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"101651","DOI":"10.1016\/j.pdpdt.2020.101651","article-title":"Antimicrobial photodynamic and photobiomodulation adjuvant therapies for prevention and treatment of medication-related osteonecrosis of the jaws: Case series and long-term follow-up","volume":"29","author":"Tartaroti","year":"2020","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Zheng, Y., Dong, X., Chen, S., He, Y., An, J., Liu, M., He, L., and Zhang, Y. (2023). Low-level laser therapy prevents medication-related osteonecrosis of the jaw-like lesions via IL-1RA-mediated primary gingival wound healing. BMC Oral Health, 23.","DOI":"10.1186\/s12903-022-02678-1"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s40001-024-01907-3","article-title":"Comparing the effects of low-level laser therapy and gaseous ozone as a preventive measure on medication-related osteonecrosis of the jaws following tooth extraction: A rat model","volume":"29","author":"Toru","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Reis, C.H.B., Buchaim, D.V., Ortiz, A.D.C., Fideles, S.O.M., Dias, J.A., Miglino, M.A., Teixeira, D.D.B., Pereira, E.D.S.B.M., da Cunha, M.R., and Buchaim, R.L. (2022). Application of Fibrin Associated with Photobiomodulation as a Promising Strategy to Improve Regeneration in Tissue Engineering: A Systematic Review. Polymers, 14.","DOI":"10.3390\/polym14153150"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s10103-020-03216-7","article-title":"Comparison of photobiomodulation in the treatment of skin injury with an open wound in mice","volume":"36","author":"Hendler","year":"2021","journal-title":"Lasers Med. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/11532600-000000000-00000","article-title":"Pentoxifylline in Preterm Neonates","volume":"12","author":"Harris","year":"2010","journal-title":"Pediatr. Drugs"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bjoms.2016.12.006","article-title":"Pentoxifylline\u2014A review of its use in osteoradionecrosis","volume":"55","author":"Lyons","year":"2017","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jcms.2020.09.008","article-title":"Pentoxifylline and tocopherol protocol to treat medication-related osteonecrosis of the jaw: A systematic literature review","volume":"48","author":"Cavalcante","year":"2020","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.oooo.2019.08.004","article-title":"Systematic review of the use of pentoxifylline and tocopherol for the treatment of medication-related osteonecrosis of the jaw","volume":"128","author":"Abdelsamie","year":"2019","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"100345","DOI":"10.1016\/j.adoms.2022.100345","article-title":"Is the combination of pentoxifylline and tocopherol really effective in the treatment of drug-induced osteonecrosis of the jaws? Literature review","volume":"8","author":"Essaket","year":"2022","journal-title":"Adv. Oral Maxillofac. Surg."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Michalak, F., Hnitecka, S., Dominiak, M., and Grzech-Le\u015bniak, K. (2021). Schemes for Drug-Induced Treatment of Osteonecrosis of Jaws with Particular Emphasis on the Influence of Vitamin D on Therapeutic Effects. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13030354"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Dalle Carbonare, L., Mottes, M., and Valenti, M.T. (2021). Medication-Related Osteonecrosis of the Jaw (MRONJ): Are Antiresorptive Drugs the Main Culprits or Only Accomplices? The Triggering Role of Vitamin D Deficiency. Nutrients, 13.","DOI":"10.3390\/nu13020561"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4103\/njcp.njcp_374_19","article-title":"Changes in serological bone turnover markers in bisphosphonate induced osteonecrosis of the jaws: A case control study","volume":"23","author":"Demircan","year":"2020","journal-title":"Niger. J. Clin. Pract."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/14397595.2017.1308454","article-title":"Comparison of the effects of denosumab with either active vitamin D or native vitamin D on bone mineral density and bone turnover markers in postmenopausal osteoporosis","volume":"28","author":"Suzuki","year":"2018","journal-title":"Mod. Rheumatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mehy.2018.04.023","article-title":"Vitamin D supplementation: Hypothetical effect on medication-related osteonecrosis of the jaw","volume":"116","author":"Carballo","year":"2018","journal-title":"Med. Hypotheses"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.intimp.2017.03.021","article-title":"Vitamin D reduces the inflammatory response by Porphyromonas gingivalis infection by modulating human \u03b2-defensin-3 in human gingival epithelium and periodontal ligament cells","volume":"47","author":"Fiorentino","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.jds.2023.01.021","article-title":"Drug holiday of high-dose denosumab and recovery from osteoclast inhibition using immunohistochemical investigation of 7 patients with medication-related osteonecrosis of the jaw undergoing segmental mandibulectomy","volume":"18","author":"Sawada","year":"2023","journal-title":"J. Dent. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.oooo.2021.06.003","article-title":"Tooth extractions in patients with cancer receiving high-dose antiresorptive medication: A randomized clinical feasibility trial of drug holiday versus drug continuation","volume":"133","author":"Ottesen","year":"2022","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1038\/s41467-025-59718-x","article-title":"Time since last intravenous bisphosphonate and risk of osteonecrosis of the jaw in osteoporotic patients","volume":"16","author":"Park","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/jbmr.4119","article-title":"A Drug Holiday Reduces the Frequency and Severity of Medication-Related Osteonecrosis of the Jaw in a Minipig Model","volume":"35","author":"Otto","year":"2020","journal-title":"J. Bone Miner. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jcms.2015.08.008","article-title":"Perioperative discontinuation of intravenous bisphosphonate therapy reduces the incidence and severity of bisphosphonate-related osteonecrosis of the jaw: A randomized, controlled, prospective experimental study in rats","volume":"43","author":"Zandi","year":"2015","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_67","first-page":"2793","article-title":"Effect of Oral Bisphosphonate Drug Holiday on Mortality Following Hip Fracture","volume":"109","author":"Leung","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/odi.12489","article-title":"Hyperbaric oxygen therapy and osteonecrosis","volume":"23","author":"Ceponis","year":"2017","journal-title":"Oral Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"241","DOI":"10.22462\/04.06.2020.10","article-title":"Management of stage 0 medication-related osteonecrosis of the jaw with hyperbaric oxygen therapy: A case report and review of the literature","volume":"47","author":"Lin","year":"2020","journal-title":"Undersea Hyperb. Med."},{"key":"ref_70","first-page":"CD012432","article-title":"Interventions for managing medication-related osteonecrosis of the jaw","volume":"2022","author":"Mayer","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00784-023-05410-7","article-title":"Hyperbaric oxygen therapy as an adjunct treatment of periodontitis, MRONJ, and ONJ: A systematic literature review","volume":"28","author":"Heck","year":"2024","journal-title":"Clin. Oral Investig."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/JPER.18-0761","article-title":"Immediate hyperbaric oxygen after tooth extraction ameliorates bisphosphonate-related osteonecrotic lesion in rats","volume":"90","author":"Liu","year":"2019","journal-title":"J. Periodontol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1007\/s00784-019-03117-2","article-title":"Impact of Hyperbaric Oxygen on the Healing of Teeth Extraction Sockets and Alveolar Ridge Preservation","volume":"24","author":"Liao","year":"2020","journal-title":"Clin. Oral Investig."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1200\/JCO.23.02750","article-title":"Prevention and Management of Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy: ISOO-MASCC-ASCO Guideline","volume":"42","author":"Peterson","year":"2024","journal-title":"J. Clin. Oncol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7539\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:10:47Z","timestamp":1787890247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,23]]},"references-count":74,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27177539"],"URL":"https:\/\/doi.org\/10.3390\/ijms27177539","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,23]]}}}